Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2023-04-04 | New | $9,109,912 | $9,109,912 | Equity Only | 06b | SEC link |
| 2019-08-15 | New | $54,999,994 | $54,999,994 | Equity Only | 06b | SEC link |
| 2018-06-13 | Amended | $75,393,829 | $42,450,133 | Equity Only | 06b | SEC link |
| 2017-07-18 | Amended | $32,943,696 | $11,999,997 | Equity Only | 06b | SEC link |
| 2016-05-13 | New | $20,943,699 | $20,943,699 | Equity Only | 06b | SEC link |
| 2015-12-21 | New | $750,000 | $750,000 | Debt Only | 06b | SEC link |
| 2015-03-06 | New | $1,740,000 | $1,740,000 | Equity Only | 06b | SEC link |
| 2014-10-07 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| 2013-10-10 | Amended | $1,455,000 | $250,000 | Equity Only | 06b | SEC link |
| 2013-09-18 | New | $1,205,000 | $1,205,000 | Equity Only | 06 | SEC link |
| 2011-11-08 | New | $610,000 | $610,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Eric Bjerkholt | Director |
| Gerald Cagle | Director |
| Gerald Cagle, Ph.D. | Director |
| Jeffrey Cleland | Director, Executive |
| Emmett Cunningham | Director |
| Emmett Cunningham, M.D., Ph.D. | Director |
| Michael J. Dunn | Executive |
| Daniel Geffken | Executive |
| Frederic Guerard | Director |
| Justin Hanes | Director |
| Sudarshan Hebbar | Executive |
| Hansoo Michael Keyoung | Director |
| Chau Khoung | Director |
| Chau Khuong | Director |
| A. Rachel Leheny | Director, Executive |
| Fred Middleton | Director |
| Michael O'rourke | Director, Executive |
| Eric W. Roberts | Director, Executive |
| Christy Shaffer | Director |
| Christy Shaffer, Ph.D. | Director |
| Allan Shaw | Director |
| Kenneth A. Stauderman | Executive |
| Pamela Wapnick | Executive, Promoter |
| Cameron Wheeler | Director |
| Cameron Wheeler, Ph.D. | Director |
| Robert N. Wilson | Director |
| Christy Wyskiel | Executive |